Saraswati Vaidyanathan Sukumar

This inventor holds 20 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Methylation Analysis. Top assignees: Johns Hopkins University, Genzyme Corporation. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saraswati Vaidyanathan Sukumar. Retrieved from https://idiyas.com/inventor/saraswati-vaidyanathan-sukumar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 7)

% Patents Active = 80.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 277(Granted Patents)

Location History:

Columbia, MA (US) (2007)
Columbia, MD (US) (1998 - 2019)

Company Filing History:

20 out of 3,801

Johns Hopkins University

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Methylation Specific PCR

Breast Cancer

Tamoxifen Resistance

Gene Markers

Neoplasia

Therapeutic Targets

Diagnostic Markers

Endothelial Cell Patterns

Aberrantly Methylated Genes

Ductal Epithelium Treatment

Prophylactic Treatment

Cancer Prognosis

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448650 - Quantitative multiplex methylation specific PCR method-CMethDNA, reagents, and its use (2025-10-21),

2. 10450609 - Quantitative multiplex methylation specific PCR method—cMethDNA, reagents, and its use (2019-10-22),

3. 10316361 - Genome-wide methylation analysis and use to identify genes specific to breast cancer hormone receptor status and risk of recurrence (2019-06-11),

4. 9540694 - HEYL as a therapeutic target and a diagnostic marker for neoplasia and uses therefor (2017-01-10),

5. 9416404 - Quantitative multiplex methylation-specific PCR (2016-08-16),

6. 9062308 - Compositions and methods for treatment of tamoxifen resistant breast cancer (2015-06-23),

7. 8822155 - Quantitative multiplex methylation-specific PCR (2014-09-02),

8. 8568985 - Breast endothelial cell expression patterns (2013-10-29),

9. 8093013 - Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer (2012-01-10),

10. 8062849 - Quantitative multiplex methylation-specific PCR (2011-11-22),

11. 7858317 - Aberrantly methylated genes as markers of breast malignancy (2010-12-28),

12. 7196070 - Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancer (2007-03-27),

13. 6932777 - Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancer (2005-08-23),

14. 6835541 - Aberrantly methylated genes as markers of breast malignancy (2004-12-28),

15. 6756200 - Aberrantly methylated genes as markers of breast malignancy (2004-06-29),

Title: The Innovative Journey of Saraswati Vaidyanathan Sukumar

Introduction: Saraswati Vaidyanathan Sukumar is a pioneering inventor based in Columbia, MD, known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Saraswati Vaidyanathan Sukumar holds several patents in the areas of artificial intelligence, machine learning, and data analytics, showcasing her commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Sukumar has worked with leading tech companies, research institutions, and universities, honing her skills and expertise in developing cutting-edge solutions that have revolutionized the industry.

Collaborations: Throughout her career, Saraswati Vaidyanathan Sukumar has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and knowledge-sharing that has led to the development of transformative technologies.

Conclusion: Saraswati Vaidyanathan Sukumar's relentless pursuit of innovation and her passion for creating solutions that make a difference have solidified her reputation as a trailblazer in the world of technology. Her work continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.